Titan Medical Inc (TMDIF)

[SMirza_007]

Titan’s Enos™ single port robotic-assisted, minimally invasive surgical system represents a direct competitor to ISRG’s da Vinci surgical system and makes Titan a buyout target for Medtronic, a Company with over $100 billion in assets. Titan is looking much better than it did just a few months ago; the Company has $24,675,913 in the treasury, compared with cash and cash equivalents of $814,492 as of December 31, 2019.